Share this Story: Clear link between AstraZeneca and rare blood clots in brain, EMA vaccine chief saysClear link between AstraZeneca and rare blood clots in brain, EMA vaccine chief says 'In my opinion, we can now say it,' said Marco Cavaleri, chair of the vaccine evaluation team at the European Medicines Agency Photo by GABRIEL BOUYS / AFP via Getty ImagesArticle content There is a link between AstraZeneca’s COVID-19 vaccine and very rare blood clots in the brain but the possible causes are still unknown, a senior official for the European Medicines Agency (EMA) said in an interview published on Tuesday. Scientists are exploring several possibilities that might explain the extremely rare brain blood clots that occurred in individuals in the days and weeks after receiving the AstraZeneca vaccine. Some countries limit AstraZeneca vaccine use amid concern over blood clots Some countries are restricting use of the AstraZeneca vaccine against COVID-19 while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue. FINLAND: Resumed using the AstraZeneca vaccine from March 29, but will only give it to people aged 65 and over. GERMANY: From March 31, Germany limited use of the shot to people over 60 and high-priority groups, following further reports of a rare brain blood disorder.

Source: National Post April 06, 2021 11:48 UTC